The Promise of Indigenous Epigenetics
By Emma Kowal,
Discover Society
| 10. 04. 2016
For the last two decades, Indigenous peoples have consistently resisted genetics on local, national and international scales. Awareness of genetics as a potentially harmful science spread through Indigenous organisations in the mid 1990s after the U.S. National Institutes of Health attempted to patent a virus found in the blood of a Papua New Guinean man, and the Human Genome Diversity Project attempted to collect DNA samples from indigenous peoples, who they called ‘Isolates of Historical Interest’, from around the world (Reardon 2005). The U.S.-based NGO Indigenous Peoples Council on Biocolonialism was formed in response.
Although genetics has transformed in the ‘post-genomic’ age (a term used for the period after the human genome was sequenced), its reputation among Indigenous peoples continues to be strained. Genetics is often seen as deterministic and victim-blaming, diverting attention and resources from social and political causes of ill-health, reinforcing ideologies of Indigenous inferiority within Western science, facilitating the theft of genetic biological resources and knowledge, and as the source of inflated, unjustified hype that offers little or no benefit to Indigenous people (TallBear 2013).
Adding the...
Related Articles
By Matt Novak, Gizmodo | 07.23.2025
Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, Kennedy recently told Tucker Carlson that AI...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...